UB Paderborn / Katalog / Suche / in CDI

4-Phenylpyrrolo[3,4-c]carbazole-1,3(2H,6H)-dione Inhibitors of the Checkpoint Kinase Wee1. Structure−Activity Relationships for Chromophore Modification and Phenyl Ring Substitution

Journal of medicinal chemistry, 2006-08, Vol.49 (16), p.4896-4911

2006

Link zum Volltext

Verfügbarkeit prüfen

Structure-Based Design of a Potent, Selective, and Irreversible Inhibitor of the Catalytic Domain of the erbB Receptor Subfamily of Protein Tyrosine Kinases

Journal of medicinal chemistry, 1997-03, Vol.40 (7), p.1130-1135

1997

Link zum Volltext

Verfügbarkeit prüfen

Pyrido[2,3-d]pyrimidin-7-ones as Specific Inhibitors of Cyclin-Dependent Kinase 4

Journal of medicinal chemistry, 2005-04, Vol.48 (7), p.2371-2387

2005

Link zum Volltext

Verfügbarkeit prüfen

Specific, Irreversible Inactivation of the Epidermal Growth Factor Receptor and erbB2, by a New Class of Tyrosine Kinase Inhibitor

Proceedings of the National Academy of Sciences - PNAS, 1998-09, Vol.95 (20), p.12022-12027

1998

Link zum Volltext

Verfügbarkeit prüfen

Tyrosine Kinase Inhibitors. 15. 4-(Phenylamino)quinazoline and 4-(Phenylamino)pyrido[d]pyrimidine Acrylamides as Irreversible Inhibitors of the ATP Binding Site of the Epidermal Growth Factor Receptor

Journal of medicinal chemistry, 1999-05, Vol.42 (10), p.1803-1815

1999

Link zum Volltext

Verfügbarkeit prüfen

Structure–activity relationships for 2-anilino-6-phenylpyrido[2,3- d]pyrimidin-7(8 H)-ones as inhibitors of the cellular checkpoint kinase Wee1

Bioorganic & medicinal chemistry letters, 2005-04, Vol.15 (7), p.1931-1935

2005

Link zum Volltext

Verfügbarkeit prüfen

Synthesis and structure–activity relationships of N-6 substituted analogues of 9-hydroxy-4-phenylpyrrolo[3,4- c]carbazole-1,3(2 H,6 H)-diones as inhibitors of Wee1 and Chk1 checkpoint kinases

European journal of medicinal chemistry, 2008-06, Vol.43 (6), p.1276-1296

2008

Link zum Volltext

Verfügbarkeit prüfen

2-Aminoquinazoline inhibitors of cyclin-dependent kinases

Bioorganic & medicinal chemistry letters, 2005-09, Vol.15 (17), p.3881-3885

2005

Link zum Volltext

Verfügbarkeit prüfen

Substrate Specificity of the Protein Tyrosine Phosphatases

Proceedings of the National Academy of Sciences - PNAS, 1993-05, Vol.90 (10), p.4446-4450

1993

Link zum Volltext

Verfügbarkeit prüfen

Tyrosine Kinase Inhibitors. 3. Structure-Activity Relationships for Inhibition of Protein Tyrosine Kinases by Nuclear-Substituted Derivatives of 2,2'-Dithiobis(1-methyl-N-phenyl-1H-indole-3-carboxamide)

Journal of medicinal chemistry, 1994-06, Vol.37 (13), p.2033-2042

1994

Link zum Volltext

Verfügbarkeit prüfen

Tyrosine kinase inhibitors. 1. Structure-activity relationships for inhibition of epidermal growth factor receptor tyrosine kinase activity by 2,3-dihydro-2-thioxo-1H-indole-3-alkanoic acids and 2,2'-dithiobis(1H-indole-3-alkanoic acids)

Journal of medicinal chemistry, 1993-08, Vol.36 (17), p.2459-2469

1993

Link zum Volltext

Verfügbarkeit prüfen

Determinants of Substrate Recognition in the Protein-tyrosine Phosphatase, PTP1 (∗)

The Journal of biological chemistry, 1996-03, Vol.271 (10), p.5386-5392

1996

Link zum Volltext

Verfügbarkeit prüfen

Identification of Amino Acids in the N-Terminal SH2 Domain of Phospholipase C.gamma.1 Important in the Interaction with Epidermal Growth Factor Receptor

Biochemistry (Easton), 1994-12, Vol.33 (49), p.14671-14678

1994

Link zum Volltext

Verfügbarkeit prüfen

Sequence specificity in recognition of the epidermal growth factor receptor by protein tyrosine phosphatase 1B

The Journal of biological chemistry, 1993-11, Vol.268 (31), p.23634-23639

1993

Link zum Volltext

Verfügbarkeit prüfen

Synthesis and structure-activity relationships of N-6 substituted analogues of 9-hydroxy-4-phenylpyrrolo[3,4-c]carbazole-1,3(2H,6H )diones as inhibitors of Weel and Chkl checkpoint kinases

European journal of medicinal chemistry, 2008, Vol.43 (6), p.1276-1296

2008

Link zum Volltext

Verfügbarkeit prüfen

4-phenylpyrrolo[3,4-c]carbazole-1,3(2H,6H)-dione inhibitors of the checkpoint kinase weel. Structure-activity relationships for chromophore modification and phenyl ring substitution

Journal of medicinal chemistry, 2006, Vol.49 (16), p.4896-4911

2006

Link zum Volltext

Verfügbarkeit prüfen

Structure-activity relationships for 2-anilino-6-phenylpyrido[2,3-d]pyrimidin-7(8H)-ones as inhibitors of the cellular checkpoint kinase Weel

Bioorganic & medicinal chemistry letters, 2005, Vol.15 (7), p.1931-1935

2005

Link zum Volltext

Verfügbarkeit prüfen

Chapter 18. Protein Tyrosine Kinases and Cancer

Annual Reports in Medicinal Chemistry, 1992, Vol.27, p.169-178

1992

Link zum Volltext

Verfügbarkeit prüfen

Differentiation of peptide molecular recognition by phospholipase Cγ‐1 Src homology‐2 domain and a mutant Tyr phosphatase PTP1bC215S

Protein science, 1995-01, Vol.4 (1), p.13-20

1995

Link zum Volltext

Verfügbarkeit prüfen

Differentiation of peptide molecular recognition by phospholipase Cγ‐1 Src homology‐2 domain and a mutant Tyr phosphatase PTP1b C215S

Protein science, 1995-01, Vol.4 (1), p.13-20

1995

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of binding of phospholipase Cγ1 SH2 domains to phosphorylated epidermal growth factor receptor by phosphorylated peptides

International Journal of Peptide and Protein Research, 1993-09, Vol.42 (3), p.240-248

1993

Link zum Volltext

Verfügbarkeit prüfen

2-Aminoquinazoline Inhibitors of Cyclin-Dependent Kinases

ChemInform, 2005-12, Vol.36 (51), p.no-no

2005

Link zum Volltext

Verfügbarkeit prüfen

Structure-Activity Relationships for 2-Anilino-6-phenylpyrido[2,3-d]pyrimidin-7(8H)-ones as Inhibitors of the Cellular Checkpoint Kinase Wee1

ChemInform, 2005-08, Vol.36 (31), p.no-no

2005

Link zum Volltext

Verfügbarkeit prüfen

Unequivocal Synthesis of 6- and 7-Substituted Thiazolo[3,2-a]benzimidazoles

19th International Congress of Heterocyclic Chemistry, 2003, p.296-296

2003

Link zum Volltext

Verfügbarkeit prüfen

Pyrido[2,3-d]pyrimidin-7-one Inhibitors of Cyclin-Dependent Kinases

Journal of medicinal chemistry, 2000-11, Vol.43 (24), p.4606-4616

2000

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

4-Phenylpyrrolo[3,4-c]carbazole-1,3(2H,6H)-dione Inhibitors of the Checkpoint Kinase Wee1. Structure−Activity Relationships for Chromophore Modification and Phenyl Ring Substitution

Structure-Based Design of a Potent, Selective, and Irreversible Inhibitor of the Catalytic Domain of the erbB Receptor Subfamily of Protein Tyrosine Kinases

Pyrido[2,3-d]pyrimidin-7-ones as Specific Inhibitors of Cyclin-Dependent Kinase 4

Specific, Irreversible Inactivation of the Epidermal Growth Factor Receptor and erbB2, by a New Class of Tyrosine Kinase Inhibitor

Tyrosine Kinase Inhibitors. 15. 4-(Phenylamino)quinazoline and 4-(Phenylamino)pyrido[d]pyrimidine Acrylamides as Irreversible Inhibitors of the ATP Binding Site of the Epidermal Growth Factor Receptor

Structure–activity relationships for 2-anilino-6-phenylpyrido[2,3- d]pyrimidin-7(8 H)-ones as inhibitors of the cellular checkpoint kinase Wee1

Synthesis and structure–activity relationships of N-6 substituted analogues of 9-hydroxy-4-phenylpyrrolo[3,4- c]carbazole-1,3(2 H,6 H)-diones as inhibitors of Wee1 and Chk1 checkpoint kinases

2-Aminoquinazoline inhibitors of cyclin-dependent kinases

Substrate Specificity of the Protein Tyrosine Phosphatases

Tyrosine Kinase Inhibitors. 3. Structure-Activity Relationships for Inhibition of Protein Tyrosine Kinases by Nuclear-Substituted Derivatives of 2,2'-Dithiobis(1-methyl-N-phenyl-1H-indole-3-carboxamide)

Tyrosine kinase inhibitors. 1. Structure-activity relationships for inhibition of epidermal growth factor receptor tyrosine kinase activity by 2,3-dihydro-2-thioxo-1H-indole-3-alkanoic acids and 2,2'-dithiobis(1H-indole-3-alkanoic acids)

Determinants of Substrate Recognition in the Protein-tyrosine Phosphatase, PTP1 (∗)

Identification of Amino Acids in the N-Terminal SH2 Domain of Phospholipase C.gamma.1 Important in the Interaction with Epidermal Growth Factor Receptor

Sequence specificity in recognition of the epidermal growth factor receptor by protein tyrosine phosphatase 1B

Synthesis and structure-activity relationships of N-6 substituted analogues of 9-hydroxy-4-phenylpyrrolo[3,4-c]carbazole-1,3(2H,6H )diones as inhibitors of Weel and Chkl checkpoint kinases

4-phenylpyrrolo[3,4-c]carbazole-1,3(2H,6H)-dione inhibitors of the checkpoint kinase weel. Structure-activity relationships for chromophore modification and phenyl ring substitution

Structure-activity relationships for 2-anilino-6-phenylpyrido[2,3-d]pyrimidin-7(8H)-ones as inhibitors of the cellular checkpoint kinase Weel

Chapter 18. Protein Tyrosine Kinases and Cancer

Differentiation of peptide molecular recognition by phospholipase Cγ‐1 Src homology‐2 domain and a mutant Tyr phosphatase PTP1bC215S

Differentiation of peptide molecular recognition by phospholipase Cγ‐1 Src homology‐2 domain and a mutant Tyr phosphatase PTP1b C215S

Inhibition of binding of phospholipase Cγ1 SH2 domains to phosphorylated epidermal growth factor receptor by phosphorylated peptides

2-Aminoquinazoline Inhibitors of Cyclin-Dependent Kinases

Structure-Activity Relationships for 2-Anilino-6-phenylpyrido[2,3-d]pyrimidin-7(8H)-ones as Inhibitors of the Cellular Checkpoint Kinase Wee1

Unequivocal Synthesis of 6- and 7-Substituted Thiazolo[3,2-a]benzimidazoles

Pyrido[2,3-d]pyrimidin-7-one Inhibitors of Cyclin-Dependent Kinases

Suchergebnisse filtern